This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigation

Authoring team

Purpose of investigations in nephrotic syndrome (NS) is

  • (1) confirm the clinical diagnosis;
  • (2) seek a possible cause;
  • (3) assess renal function; and
  • (4) identify biochemical disorders related to the nephrotic state e.g. hypercoagulability, hypovolaemia, hyperlipidaemia

Finding of heavy proteinuria (3-4+) on dipstick and oedema in a child in the developed world usually means a diagnosis of NS. Proteinuria needs to be quantified as the protein: creatinine ratio or per litre of urine

  • proteinuria is usually measured on first morning spot voids
    • microscopic haematuria may be present in up to 25% of children with steroid-sensitive NS and should not be a contraindication to empirical steroid therapy
  • recommended investigations in a child (2)
    • urine dipstick analysis (protein and blood)
    • first morning urine for protein:creatinine ratio
    • urine for microscopy, sensitivity and culture
    • serum electrolytes, albumin, triglyceride and cholesterol, calcium
    • FBC
      • haemoglobin and packed cell volume
    • complement C3 and C4 levels
    • varicella zoster serology
    • hepatitis B and C serology
    • ASO titre, anti-DNAse B, lupus antibody serology (ANA, ENA, ds- DNA), ANCA if atypical presenting features

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.